Ligamax
Payments companies reported to CMS as associated with Ligamax. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ligamax, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ligamax
These are the largest totals companies reported as associated with Ligamax. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jon Yamaguchi | Honolulu, HI | Transplant Surgery | $88.66 |
| Steven Kim | Littleton, CO | Surgery | $58.31 |
| Steven Fowler | Honolulu, HI | Surgery | $45.15 |
| Paul Lin | Washington, DC | Surgery | $40.09 |
| Nicole Chappell | Washington, DC | Gynecologic Oncology | $40.09 |
| Khashayar Vaziri | Washington, DC | Surgery | $40.09 |
| Juliet Lee | Washington, DC | Surgery | $40.09 |
| Jacqueline Lee | Stanford, CA | Surgery | $38.75 |
| Christopher Finley | Port Charlotte, FL | Surgery | $27.80 |
| Heather Zeznock | Wasilla, AK | Surgery | $25.80 |
Prescribed Ligamax?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.